Delivery Order SPE2DB24D2205-SPE2DB24FDTTT
Award Date
5/7/24
Potential Completion Date
5/8/24
Potential Value
$1.4K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA), a defense agency, to Amerisourcebergen Drug Corp's Corporate Office Division. The contract is for the delivery of 4,564,977,682 units of insulin degludec pen (U-200) 3ML, with an ultimate completion date of June 24, 2024 and a ceiling value of $3,934.74. The contract is a Delivery Order with a Firm Fixed Price pricing type. It does not have a set-aside designation. Amerisourcebergen Drug Corp is a major supplier of...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,962.88 firm-fixed-price delivery order is for the supply of insulin degludec pens (U-200, 3mL) to support military healthcare programs. The contract has an ultimate completion date of January 31, 2025. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This federal contract award to Amerisourcebergen Drug Corp is a Delivery Order valued at $1,313.56 for the supply of Insulin Degludec Pen (U-200) 3ML. The contract was awarded by the Defense Logistics Agency (DLA) Troop Support Medical, a major defense agency. This award is part of a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999, that enables the agency to efficiently procure a comprehensive range of pharmaceutical and medical supplies...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,289.17 firm fixed-price delivery order is for the supply of Insulin Degludec Pen (U-100) 3mL, a critical medical product used in the management of diabetes. This award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which serves...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,471.35, is for the supply of Insulin Degludec Pen (U-200) 3ML, a critical medical commodity for federal healthcare programs. The contract has an ultimate completion date of January 8, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $13,788.60 firm fixed-price delivery order is for the supply of insulin glargine-yfgn U100 pens, with a completion date of December 24, 2024. The award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, which provides a comprehensive...
This is a federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division, a major pharmaceutical distributor, to supply Insulin Aspart 100 Unit/ML Pen 3ML to the U.S. Department of Defense (DoD) and its agencies. The $2,379.74 Firm Fixed Price Delivery Order contract has an ultimate completion date of April 22, 2024. Amerisourcebergen holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop Support Medical to provide a...
The U.S. Department of Defense (DOD) has awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to supply 4,564,184,917 units of Insulin Degludec Pens (U-200) 3ML. The contract, valued at $4,137.57, has an ultimate completion date of April 8, 2024. AmerisourceBergen Drug Corp is the prime contractor on this delivery order, which is issued under a larger $999,999,999.00 indefinite delivery contract (IDC) awarded by the...
This federal contract award was made by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The contract is a firm fixed price delivery order for insulin glargine-yfgn U100 pens, with a ceiling value of $29,447.88 and a period of performance through March 21, 2024. Amerisourcebergen Drug Corp is the prime contractor, and no small business...
This federal contract award, valued at $4,091.04, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The award is for the delivery of insulin glargine-yfgn U100 pens, a critical diabetes management medication, with a completion date of December 19, 2024. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and running...